KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Merck (MRK) Other financing activities (2016 - 2025)

Historic Other financing activities for Merck (MRK) over the last 17 years, with Q3 2025 value amounting to $2.0 million.

  • Merck's Other financing activities rose 10625.0% to $2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$294.0 million, marking a year-over-year increase of 1171.17%. This contributed to the annual value of -$372.0 million for FY2024, which is 1341.46% down from last year.
  • Per Merck's latest filing, its Other financing activities stood at $2.0 million for Q3 2025, which was up 10625.0% from -$194.0 million recorded in Q2 2025.
  • Merck's Other financing activities' 5-year high stood at $35.0 million during Q3 2022, with a 5-year trough of -$407.0 million in Q2 2021.
  • Moreover, its 5-year median value for Other financing activities was -$78.0 million (2024), whereas its average is -$99.8 million.
  • In the last 5 years, Merck's Other financing activities crashed by 130000.0% in 2024 and then soared by 10625.0% in 2025.
  • Merck's Other financing activities (Quarter) stood at -$407.0 million in 2021, then skyrocketed by 83.29% to -$68.0 million in 2022, then surged by 95.59% to -$3.0 million in 2023, then tumbled by 1300.0% to -$42.0 million in 2024, then surged by 104.76% to $2.0 million in 2025.
  • Its Other financing activities stands at $2.0 million for Q3 2025, versus -$194.0 million for Q2 2025 and -$60.0 million for Q1 2025.